NCT05291871View on ClinicalTrials.gov

Immunogenicity of Fractional Dose of the HPV Vaccines

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
HPV InfectionHPV Vaccine
Interventions
BIOLOGICAL

HPV vaccine

One-fifth dose bivalent HPV Vaccine or One-fifth dose nonavalent HPV Vaccine

Trial Locations (1)

98104

University of Washington Virology Research Clinic, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT05291871 - Immunogenicity of Fractional Dose of the HPV Vaccines | Biotech Hunter | Biotech Hunter